• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

The economics of blood: gift of life or a commodity?

作者信息

Kanavos Panos, Yfantopoulos John, Vandoros Christina, Politis Costantina

机构信息

LSE Health, London School of Economics, UK.

出版信息

Int J Technol Assess Health Care. 2006 Summer;22(3):338-43. doi: 10.1017/s0266462306051233.

DOI:10.1017/s0266462306051233
PMID:16984062
Abstract

OBJECTIVES

To calculate the costs of blood collection, testing, storage, and transfusion in Greece.

METHODS

Costing information was collected from two large public hospitals, in Athens and Crete, that also act as blood banks. Given that private health care accounts for 40 percent of total health spending, the same costs were also considered in a private setting by collecting key reagent cost data from a leading private hospital in Athens. Mainly direct costs were considered (advertising campaigns, personnel, storage and maintenance, reagent costs, transportation costs from blood bank to end-use hospitals, and cross-matching and transfusion costs in receiving hospitals) and some indirect costs (opportunity cost of blood donorship).

RESULTS

Captive donorship accounts for over 50 percent of the national blood supply. A unit of blood transfused would cost between Euro 294.83 and Euro 339.83 in public hospitals and could reach Euro 413.93 in a private facility. This figure may be an underestimate, as it excludes opportunity costs of blood transfusion for patients and the healthcare system.

CONCLUSIONS

Blood has a significant cost to the health system. Policy makers and practitioners should encourage its rational use, build on current policies to further improve collection and distribution, encourage further volunteer donorship in Greece, and also consider alternatives to blood where the possibility exists.

摘要

相似文献

1
The economics of blood: gift of life or a commodity?
Int J Technol Assess Health Care. 2006 Summer;22(3):338-43. doi: 10.1017/s0266462306051233.
2
The cost of blood collection in Greece: an economic analysis.
Clin Ther. 2014 Jul 1;36(7):1028-1036.e5. doi: 10.1016/j.clinthera.2014.05.003. Epub 2014 Jun 17.
3
Blood transfusion economics in Greece.
Transfus Clin Biol. 1995;2(5):387-94. doi: 10.1016/s1246-7820(05)80083-7.
4
Costs, resource utilisation and financing of public and private hospitals in Uganda.乌干达公立和私立医院的成本、资源利用及融资情况
East Afr Med J. 1995 Sep;72(9):591-8.
5
Should hospitals collect blood components?: no.医院应该采集血液成分吗?:不应该。
Transfus Sci. 1997 Dec;18(4):545-51. doi: 10.1016/s0955-3886(97)00052-0.
6
Estimating the cost of blood: past, present, and future directions.估算血液成本:过去、现在及未来的方向
Best Pract Res Clin Anaesthesiol. 2007 Jun;21(2):271-89. doi: 10.1016/j.bpa.2007.01.002.
7
Accurate costs of blood transfusion: a microcosting of administering blood products in the United Kingdom National Health Service.输血的精确成本:英国国民医疗服务体系中血液制品输注的微观成本核算
Transfusion. 2018 Apr;58(4):846-853. doi: 10.1111/trf.14493. Epub 2018 Jan 30.
8
Payments and quality of care in private for-profit and public hospitals in Greece.希腊私立营利性医院和公立医院的支付方式和医疗质量。
BMC Health Serv Res. 2011 Sep 23;11:234. doi: 10.1186/1472-6963-11-234.
9
The societal unit cost of allogenic red blood cells and red blood cell transfusion in Canada.加拿大异体红细胞及红细胞输血的社会单位成本。
Transfusion. 2004 Oct;44(10):1479-86. doi: 10.1111/j.1537-2995.2004.04065.x.
10
A cost analysis of public cord blood banks belonging to the Italian Cord Blood Network.意大利脐血库网络所属公共脐血库的成本分析。
Blood Transfus. 2018 May;16(3):313-320. doi: 10.2450/2017.0251-16. Epub 2017 Apr 13.

引用本文的文献

1
Making patient blood management the new norm(al) as experienced by implementors in diverse countries.在不同国家的实施者看来,使患者血液管理成为新常态。
BMC Health Serv Res. 2021 Jul 2;21(1):634. doi: 10.1186/s12913-021-06484-3.
2
Cost-effectiveness of leucoreduction for prevention of febrile non-haemolytic transfusion reactions.白细胞滤除预防发热非溶血性输血反应的成本效益
Blood Transfus. 2014 Apr;12(2):232-7. doi: 10.2450/2014.0263-13.
3
Cost of post-operative intravenous iron therapy in total lower limb arthroplasty: a retrospective, matched cohort study.
全下肢关节置换术后静脉补铁治疗的成本:一项回顾性、匹配队列研究。
Blood Transfus. 2014 Jan;12(1):40-9. doi: 10.2450/2013.0088-13. Epub 2013 Oct 3.
4
Budget impact analysis on erythropoiesis-stimulating agents use for the management of chemotherapy-induced anaemia in Greece.用于治疗希腊化疗引起的贫血的促红细胞生成素药物的预算影响分析。
Cost Eff Resour Alloc. 2013 Jul 16;11(1):16. doi: 10.1186/1478-7547-11-16.
5
Hemoglobin level at initiation of darbepoetin alfa: impact on need for transfusion and associated costs in chemotherapy-induced anemia treatment in Europe.达贝泊汀 α 起始时的血红蛋白水平:对欧洲化疗引起的贫血治疗中输血需求和相关成本的影响。
Support Care Cancer. 2013 Feb;21(2):485-93. doi: 10.1007/s00520-012-1538-0. Epub 2012 Jul 24.
6
Economic evaluation of intravenous iron treatments in the management of anemia patients in Greece.希腊贫血患者管理中静脉铁剂治疗的经济学评估。
Clinicoecon Outcomes Res. 2012;4:127-34. doi: 10.2147/CEOR.S30514. Epub 2012 May 4.
7
Blood management by transfusion triggers: when less is more.输血触发的血液管理:少即是多。
Blood Transfus. 2012 Jan;10(1):28-33. doi: 10.2450/2011.0108-10. Epub 2011 Jun 15.